These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 28463156)

  • 21. Developing an Evidence-based Followup Schedule for Bone Sarcomas Based on Local Recurrence and Metastatic Progression.
    Cipriano C; Griffin AM; Ferguson PC; Wunder JS
    Clin Orthop Relat Res; 2017 Mar; 475(3):830-838. PubMed ID: 27339121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
    Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of carbon ion radiotherapy for primary spinal sarcoma.
    Matsumoto K; Imai R; Kamada T; Maruyama K; Tsuji H; Tsujii H; Shioyama Y; Honda H; Isu K;
    Cancer; 2013 Oct; 119(19):3496-503. PubMed ID: 23939877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High control rate in patients with chondrosarcoma of the skull base after carbon ion therapy: first report of long-term results.
    Uhl M; Mattke M; Welzel T; Oelmann J; Habl G; Jensen AD; Ellerbrock M; Haberer T; Herfarth KK; Debus J
    Cancer; 2014 May; 120(10):1579-85. PubMed ID: 24500784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma.
    Xu G; Wu H; Xu Y; Zhang Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Wang X; Mao M; Wang G; Cui P; Zhang C
    Orthop Surg; 2021 Feb; 13(1):134-144. PubMed ID: 33305494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and Validation of Single Field Multi-Ion Particle Therapy Treatments.
    Kopp B; Mein S; Dokic I; Harrabi S; Böhlen TT; Haberer T; Debus J; Abdollahi A; Mairani A
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):194-205. PubMed ID: 31610250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized phase II trial of hypofractionated proton versus carbon ion radiation therapy in patients with sacrococcygeal chordoma-the ISAC trial protocol.
    Uhl M; Edler L; Jensen AD; Habl G; Oelmann J; Röder F; Jäckel O; Debus J; Herfarth K
    Radiat Oncol; 2014 Apr; 9():100. PubMed ID: 24774721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose carbon-ion based radiotherapy of primary and recurrent sacrococcygeal chordomas: long-term clinical results of a single particle therapy center.
    Bostel T; Mattke M; Nicolay NH; Welzel T; Wollschläger D; Akbaba S; Mayer A; Sprave T; Debus J; Uhl M
    Radiat Oncol; 2020 Aug; 15(1):206. PubMed ID: 32831113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma.
    Ciernik IF; Niemierko A; Harmon DC; Kobayashi W; Chen YL; Yock TI; Ebb DH; Choy E; Raskin KA; Liebsch N; Hornicek FJ; Delaney TF
    Cancer; 2011 Oct; 117(19):4522-30. PubMed ID: 21448934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skull base chordoma and chondrosarcoma: influence of clinical and demographic factors on prognosis: a SEER analysis.
    Bohman LE; Koch M; Bailey RL; Alonso-Basanta M; Lee JY
    World Neurosurg; 2014 Nov; 82(5):806-14. PubMed ID: 25009165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proton therapy for reirradiation of progressive or recurrent chordoma.
    McDonald MW; Linton OR; Shah MV
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1107-14. PubMed ID: 24267972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton beam therapy for bone sarcomas of the skull base and spine: A retrospective nationwide multicenter study in Japan.
    Demizu Y; Mizumoto M; Onoe T; Nakamura N; Kikuchi Y; Shibata T; Okimoto T; Sakurai H; Akimoto T; Ono K; Daimon T; Murayama S
    Cancer Sci; 2017 May; 108(5):972-977. PubMed ID: 28182320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of dose escalation and proton therapy in perioperative or definitive treatment of chondrosarcoma and chordoma: An analysis of the National Cancer Data Base.
    Palm RF; Oliver DE; Yang GQ; Abuodeh Y; Naghavi AO; Johnstone PAS
    Cancer; 2019 Feb; 125(4):642-651. PubMed ID: 30644538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gamma Knife surgery for intracranial chordoma and chondrosarcoma: radiosurgical perspectives and treatment outcomes.
    Kim JH; Jung HH; Chang JH; Chang JW; Park YG; Chang WS
    J Neurosurg; 2014 Dec; 121 Suppl():188-97. PubMed ID: 25434952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypofractionated proton and carbon ion beam radiotherapy for sacrococcygeal chordoma (ISAC): An open label, randomized, stratified, phase II trial.
    Seidensaal K; Froehlke A; Lentz-Hommertgen A; Lehner B; Geisbuesch A; Meis J; Liermann J; Kudak A; Stein K; Uhl M; Tessonnier T; Mairani A; Debus J; Herfarth K
    Radiother Oncol; 2024 Sep; 198():110418. PubMed ID: 38944346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbon ion beam treatment in patients with primary and recurrent sacrococcygeal chordoma.
    Uhl M; Welzel T; Jensen A; Ellerbrock M; Haberer T; Jäkel O; Herfarth K; Debus J
    Strahlenther Onkol; 2015 Jul; 191(7):597-603. PubMed ID: 25737378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Image-guided, intensity-modulated radiation therapy (IG-IMRT) for skull base chordoma and chondrosarcoma: preliminary outcomes.
    Sahgal A; Chan MW; Atenafu EG; Masson-Cote L; Bahl G; Yu E; Millar BA; Chung C; Catton C; O'Sullivan B; Irish JC; Gilbert R; Zadeh G; Cusimano M; Gentili F; Laperriere NJ
    Neuro Oncol; 2015 Jun; 17(6):889-94. PubMed ID: 25543126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbon ion radiotherapy for unresectable retroperitoneal sarcomas.
    Serizawa I; Kagei K; Kamada T; Imai R; Sugahara S; Okada T; Tsuji H; Ito H; Tsujii H
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1105-10. PubMed ID: 19467578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of potential advantages of relevant ions for particle therapy: a model based study.
    Grün R; Friedrich T; Krämer M; Zink K; Durante M; Engenhart-Cabillic R; Scholz M
    Med Phys; 2015 Feb; 42(2):1037-47. PubMed ID: 25652516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma.
    Blattmann C; Oertel S; Schulz-Ertner D; Rieken S; Haufe S; Ewerbeck V; Unterberg A; Karapanagiotou-Schenkel I; Combs SE; Nikoghosyan A; Bischof M; Jäkel O; Huber P; Kulozik AE; Debus J
    BMC Cancer; 2010 Mar; 10():96. PubMed ID: 20226028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.